Who
Hillel Galitzer
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Entera Bio.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2022
- Last trade
- 7 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —72,993 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —72,993 at $0.00 | filing |
| 28 Apr 2025filed 30 Apr 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 Apr 2025filed 30 Apr 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —26,316 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —30,151 at $0.00 | filing |
| 24 Apr 2023filed 25 Apr 2023 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
| 31 Mar 2022filed 4 Apr 2022 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.